Chew LD, Bradley KA, Boyko EJ
Key Take-Aways About Weight Loss Meds What Are GLP-1 Weight Loss Injections and Why Is Everyone Obsessed
At the end of week 16, the use of semaglutide was discontinued and the participants underwent regular follow-up outpatient controls to monitor their anthropometric, biochemical and hormonal parameters
Competing Interests Professor Melanie Davies has acted as a consultant/advisor and speaker for Eli Lilly, Novo Nordisk and Sanofi, has attended advisory boards for Abbvie, Amgen, AstraZeneca, Biomea Fusion, Carmot/Roche, Sanofi, Zealand Pharma Regeneron, GSK and EktaH and as a speaker for AstraZeneca and Boehringer Ingelheim
Functional importance of GLP-1 receptor species and expression levels in cell lines
Wegovy, first approved in 2021, is the only FDA-approved semaglutide treatment for weight loss